Two decades executive leadership in translational research and product innovation for cross functional corporate, clinical and academic teams.

Thought leader, change agent, educator and research director with portfolio of 180+ peer-reviewed publications in drug development, digital health and product innovation.

Listed in the Stanford index of top 1% most influential scientists in the world.

20+ years leadership in technology transfer, innovation strategy, IP portfolio development, management and licensing, technology based startups and public-private-partnerships.

Board member and advisor to startups who have raised >$4B in capital.

Technical advisor to US, Anglo and APEC governments on innovation, technology transfer and biopharmaceuticals. Key contributor for FDA guidelines on biosimilars.